FAST-FORWARD vs HAI5
ConditionCancer, Breast
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Ghent
About this trial
Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.
Eligibility criteria
Qualifiers
histopathological diagnosis of breast cancer
age 18 years or older
male or female
treated with breast conserving surgery or mastectomy with curative intent
Disqualifiers
distant metastases
decision of preoperative radiotherapy
decision of partial breast irradiation
positive resection margins ('ink on tumour')
Trial design
Treatments tested in this trial
- Questionnaire
Treatment groups
740 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov